Spectral AI, Inc. Class A (MDAI)

Spectral AI, Inc. experienced several stock events in the past six months. The company held its Q3 2025 conference call on November 11, 2025. In March 2026, Spectral AI received $31.7 million in funding from BARDA, leading to a stock rally. The company announced its Q4 and full-year 2025 financial results on March 24, 2026, reporting a net income of $0.6 million for Q4 2025 and improved cash holdings. On April 8, 2026, David McGuire was appointed as CFO, effective May 4, 2026. The company featured its DeepView System at the 2026 American Burn Association Annual Meeting on April 9, 2026. As of April 8, 2026, the share price was $1.68, a 34.40% increase from the previous year, with a 52-week high of $3.21 and a low of $1.13.

The provided information does not explicitly detail demand seasonality for Spectral AI, Inc.'s products and services. However, the company's focus on predictive medical diagnostics for wound care suggests a consistent demand rather than seasonal fluctuations. The DeepView SnapShot® M system is designed for use in military applications and home healthcare, driven by an increasing demand for portable diagnostic solutions across various healthcare settings, further suggesting a steady market.

Spectral AI, Inc. is an AI company focused on predictive medical diagnostics in the healthcare sector. Their main product, the DeepView System, uses AI and multispectral imaging to assess wound healing potential, distinguishing between different tissue characteristics. The system's initial applications target wound care for burn patients and diabetic foot ulcers, and it includes AI-Burn software.

Spectral AI, Inc. is headquartered in Dallas, Texas, United States. The DeepView system has a potential market of over 57,000 clinical care sites in the United States and more than 20,000 sites across Britain and the European Union, including hospitals and outpatient facilities.

Spectral AI's brand reputation has improved in the past year. The company was named to TIME's World's Top HealthTech Companies 2025 list, based on financial performance, reputation analysis, and online engagement. The DeepView technology received exceptional reception at burn conferences in the U.S., UK, and Europe.

Spectral AI, Inc. has a mixed ownership structure, with approximately 14.83% held by institutional shareholders, 42.84% by Spectral AI insiders, and 42.33% by retail investors. Major institutional owners include Hudson Bay Capital Management LP, Highlander Partners, L.P., and Vanguard Group Inc. The largest individual shareholder is John Michael DiMaio, owning 4.99 million shares, representing 15.67% of the company.